Beta Bionics Inc

BBNXNASDAQ · USD
19.01USD-0.40 (-2.07%)
3510

Beta Bionics Inc (BBNX) Unusual Options Activity Today

BBNX options volume power reached 1x on the previous trading day. The highest reading was on the $25 CALL expiring 2026-10-16.

Read more

Checking BBNX unusual options activity helps you spot when traders are making outsized bets on Beta Bionics Inc before the broader market catches on. Beta Bionics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor BBNX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching BBNX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking BBNX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and BBNX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing; Bihormonal iLet, which combines automated delivery of insulin and glucagon; and iLet to treat people with insulin-dependent type-2 diabetes.

It has collaboration and license agreement with Xeris Pharmaceuticals, Inc. (Xeris) to develop and commercialize a pump-compatible glucagon formulation; and development and commercialization agreement with Abbott Diabetes Care Inc. to develop and commercialize an automated insulin delivery system. The company was incorporated in 2015 and is based in Irvine, California.

Catalysts rarely arrive without a footprint, and BBNX unusual options activity is often where that footprint shows up first. Our scanner tracks Beta Bionics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at BBNX unusual options volume on the call side or chasing put sweeps, Beta Bionics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.

2026-10-16
Calls
20.00—1.901.90130%2212,200.00%
2.5016.0019.1017.55855%11100.00%
12.504.808.906.8519%9312673.81%
15.002.606.704.65102%10021247.17%
5.0013.4016.5014.95521%00—
Puts
2.50—0.050.05474%00—
5.00—0.300.30446%01200.00%
7.50—0.300.30322%01160.00%
10.00—2.602.60543%010.00%
12.50—0.050.05113%040.00%

As of September 29, 2026

Spot unusual options activity before it moves

Track BBNX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.

Start your 14-day free trial